Tuberculosis affects the human lung. If not active, the disease can remain dormant in bone marrow stem cells; © panthermedia.net/ Martin Fally
Forsyth scientists have gained new insight on how Tuberculosis (TB) remains a global epidemic. Although drugs have been available for 50 years, TB still infects nearly 2.2 billion people worldwide and causes 1.7 million annual deaths.
This is largely attributed to the bacteria's ability to stay dormant in the human body and later resurface as active disease. The Forsyth team, and its collaborators from Stanford University, has recently discovered that Mycobacterium tuberculosis (Mtb), the bacteria that causes TB, can lay dormant and thrive within bone marrow stem cells.
The microbe causes deadly disease in millions of humans and infects and persists in billions of others without causing apparent harm, yet maintaining the potential to "re-activate" and cause active tuberculosis (TB). This form of silent microbe/host interaction is known as latent or dormant TB infection. During this phase, Mtb escapes the host immune responses and survives for decades in protected niches not yet well identified. This study describes a previously unsuspected target cell used by Mtb to shield itself from the host immune system. These new findings have direct clinical implications in that they explain the reason why TB treated patients remain sensitive to TB tests for life and importantly, why TB treatment is so difficult and requires long periods of drug treatment. Moreover, these findings raise an alert for possible transmission of TB to patients undergoing bone marrow transplants with cells obtained from donors who may have latent TB.
This study was led by Doctor Antonio Campos-Neto, Director of Forsyth's Center for Global Infectious Diseases. "Tuberculosis has remained a terrible health threat despite the proliferation of knowledge, diagnostics and treatment," he said. "By gaining a greater understanding of latent TB, we can potentially save hundreds of thousands of lives each year."
Campos-Neto and his team conducted in vitro experiments, as well as in vivo using a well-defined animal model of latent TB, and from data collected from human patients treated for TB. From these studies they concluded that Mtb infects and persists in a dormant state for long periods of time within bone marrow stem cells. These cells constitute a unique niche or a sanctuary that provides the pathogen both immune privilege and protection from drug attack. Stem cells, like those infected by Mtb, are long living cells and possess a special machinery to exclude external molecules such as anti-TB drugs to enter their cytoplasm. Therefore, once inside these cells, Mtb benefits from this mechanism for its survival in a quiescent manner.
MEDICA.de; Source: Forsyth Institute